Article
Non-small cell lung cancer in the very young: Higher EGFR/ALK mutation proportion than the elder.
Journal of the Chinese Medical Association : JCMA - 1 May 2020
He Chien-Hui, Shih Jen-Fu, Lai Shinn-Liang, Chen Yuh-Min
Abstract excerpt
BACKGROUND: This study aimed to analyze pathologic characteristics, treatment, prognosis, and tumor epidermal growth factor receptor/anaplastic large-cell lymphoma kinase (EGFR/ALK) mutation proportion of non-small cell lung cancer (NSCLC) patients aged <40 years at diagnosis. METHODS: We retrospectively reviewed data of NSCLC patients diagnosed at Taipei Veterans General Hospital between June 2007 and December...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
